PECAM1 and coronary artery disorder: To quantify plasma concentrations of CD31+/CD42b−, CD62E+, and CD34+ MPs across healthy individuals and those with coronary artery disease (CAD) or acute cardiovascular events (non‐ST elevation myocardial infarction (NSTEMI)).